Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2.13 Billion | USD 4.90 Billion | 9.67% | 2023 |
The global reporter gene assay market size was worth around USD 2.13 Billion in 2023 and is predicted to grow to around USD 4.90 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 9.67% between 2024 and 2032.
The report analyzes the global reporter gene assay market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the reporter gene assay industry.
A reporter gene is a gene type that investigators assigned to a regulatory sequence of another gene of importance in cell cultures, bacteria, plants, or animals. Specific genes are selected as reporters due to their specific traits. Reporter genes can also be employed to assay the expression of a gene that may produce proteins.Request Free Sample
Rising funding for cell-based studies, growing inclination toward cell-based assays, rapidly rising applications of gene expression, increasing cancer cases, escalating demand for tailored medicines, and accelerating funding processes from government agencies will drive the reporter gene assay market globally. Increasing R&D activities and growing focus on technological innovation will generate more growth opportunities for the reporter gene assay market. However, the high research cost of cell biology, absence of skilled researchers, the dearth of latest healthcare infrastructure in developing nations, and the lack of awareness may restrict the reporter gene assay market growth globally.
Report Attributes | Report Details |
---|---|
Report Name | Reporter Gene Assay Market Research Report |
Market Size in 2023 | USD 2.13 Billion |
Market Forecast in 2032 | USD 4.90 Billion |
Growth Rate | CAGR of 9.67% |
Number of Pages | 255 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Thermo Fisher Scientific, Merck, PerkinElmer, Promega Corporation, Abcam, Biotium, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Geno Technology, InvivoGen, Genecopoeia, PromoCell, Lonza Group, Cell Signaling Technology, and General Electric, And Others |
Segments Covered | By Product, By End-User, By Application, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The reporter gene assay market is split based on product, end-user, and application. By product, the reporter gene assay market includes assay kits and reagents. Assay kits are expected to show the highest CAGR over the estimated time period, owing to their recurrent use in studies related to gene expression and signaling pathway exploration along with benefits offered by assay kits above standalone reagents. The end-user segment includes biotechnology and pharmaceutical companies, research and academic institutes, hospital and diagnostic laboratories, and contract research organizations. Biotechnology and pharmaceutical companies dominated the market in 2024. The application segment includes promoter structural and functional analysis, cell signaling pathways, protein interaction, and gene regulation.
North America will lead the reporter gene assay market globally over the forecast time period. The region accounted for over 39% of the global market in 2024, due to the major funding for life sciences studies, growing applications of personalized medicines, rapidly rising cell-based investigation activities, availability of modern healthcare facilities, and the early acceptance of latest technologies. Europe holds the second spot of the global market, due to the presence of trained researchers, huge R&D funding by major companies, rising geriatric population, increasing chronic disorder occurrences, and positive reimbursement scenario. The Asia Pacific reporter gene assay market will grow rapidly over the estimated time period, owing to the rising chronic diseases incidences, growing interest in reporter gene assay, and increasing R&D related to gene therapy.
Some key players of the reporter gene assay market are
This report segments the global reporter gene assay market into:
FrequentlyAsked Questions
A reporter gene is a gene type that investigators assigned to a regulatory sequence of another gene of importance in cell cultures, bacteria, plants, or animals. Specific genes are selected as reporters due to their specific traits.
Rising funding for cell-based studies, growing inclination toward cell-based assays, rapidly rising applications of gene expression, increasing cancer cases, escalating demand for tailored medicines, and accelerating funding processes from government agencies will drive the reporter gene assay market globally.
According to the report, the global reporter gene assay market size was worth around USD 2.13 billion in 2023 and is predicted to grow to around USD 4.90 billion by 2032.
The global reporter gene assay market is expected to grow at a CAGR of 9.67% during the forecast period.
North America will lead the reporter gene assay market globally over the forecast time period.
Some key players of the reporter gene assay market are Thermo Fisher Scientific, Merck, PerkinElmer, Promega Corporation, Abcam, Biotium, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Geno Technology, InvivoGen, Genecopoeia, PromoCell, Lonza Group, Cell Signaling Technology, and General Electric.
The global reporter gene assay market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed